Open-label test of a spectacle hearing aid to check safety and effectiveness
Official title: A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy
Run by Nuance Hearing · NCT07282028 · Data updated 2026-11-12
This will test whether a hearing aid built into eyeglasses helps adults with mild to moderate hearing loss who wear corrective glasses.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 89 (estimated) |
| Sponsor | Nuance Hearing Industry-sponsored |
| Locations | 1 site (Tel Aviv) |
| Status | Recruiting |
| Started | July 27, 2025 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | December 15, 2025 |
| Trial ID | NCT07282028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who perceive mild to moderate hearing loss, wear corrective glasses daily, are cognitively able to follow instructions, use a smartphone, and primarily communicate in Hebrew are ideal candidates.
✕Probably not a fit
People with hearing loss greater than 55 dB HL, active ear inflammation, significant cognitive or neurological impairment, recent hearing-aid use within the past 12 months, or those who do not wear glasses are unlikely to benefit from this device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, open-label pivotal trial enrolls adults with perceived mild to moderate mixed hearing loss who habitually wear corrective glasses and can use a smartphone. The study is conducted in two sequential stages (up to 30 participants in stage 1 and up to 29 in stage 2) with screening, audiometry, device calibration, fitting, and follow-up visits; stage 2 includes optometrist involvement for glasses prescriptions. Outcome measures include standard air- and bone-conduction audiometry and aided measurements, with real-ear measures optional, and safety monitoring by ENT physicians. Participants must be Hebrew speakers and attend in-person visits at the study site in Tel Aviv.
Why it matters
Potential benefit: If successful, the device could improve everyday hearing for people with mild to moderate loss by combining amplification with prescription eyewear, reducing the need for a separate hearing aid.
How similar studies have gone: Some pilot studies and early commercial devices have shown feasibility for spectacle-integrated amplification, but large pivotal efficacy data are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years and older * Perceived mild to moderate hearing loss as indicated by at least 1 positive answer to any of the signs specified by FDA: a) You have trouble hearing speech in noisy places, b) You find it hard to follow speech in groups, c) You have trouble hearing on the phone. d) Listening makes youtired, e) You need to turn up the volume on the TV or radio, and other people complain it's too loud * Wearing corrective glasses for daily use * Cognitive ability to understand and follow study instructions. * The main language used in social interactions is Hebrew * Participants must be willing to use the investigational device according to the instructions for use during the study period * Participants must be able to use a smartphone Exclusion Criteria: * Hearing loss \>55 dB HL * Prior hearing aid usages for the last 12 months * Medical history of cognitive or neurological impairment. * Active inflammatory conditions affecting the ear * Asymmetric or unilateral hearing loss - more than 15dB between ears in PTA4- based on screening or hearing test from the last 18 months. * participation in stage 1 study * Congenital ear defect or a deformed or injured ear * In the past 6 months discharge of blood, pus or fluid * Wax that might disturb REM test * Sudden hearing loss in the past 6 months * Wearer of electromagnetic medical device * Other medical conditions/medications that would interfere with subject safety or data collection in the opinion of the PI
Where it's running
-
Asssuta ramat hachayal
Tel Aviv, Israel Recruiting
Study contacts
- Study coordinator: Yael Corcos, MPH
- Email: yael@ay-impact.com
- Phone: 972-54-8106010
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transitioning from Baha Connect to Osia System in adults with mixed or conductive hearing loss
This study tests whether the Osia System is safe and performs well in adults who already use a Baha Connect system and want to switch.
-
Hearing screening for preschool children
This study is testing two different ways to check hearing in preschool children to see which method works better for finding hearing loss early and helping kids who might struggle with speech and language.
-
Evaluating long-term effects of osseointegrated devices on hearing and cognition
This study is trying to see how using special hearing devices affects the thinking and daily life of people with hearing loss over three years.
-
Comparing the maximum sound boost from different bone-anchored hearing devices.
This project will test how much extra sound three bone-anchored hearing devices can deliver for adults with mixed hearing loss.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Hearing and Brain Development in Children and Teens
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.